Intervju med Fredrik Bruhn VD på Unibap
Analyst Group intervjuar VD Fredrik Bruhn på Unibap i samband med bolagets emission.
Equity research report
2024-09-05
ODI Pharma
Comment
2024-08-29
Comment on ODI Pharma’s Quarterly Report
STENOCARE Q2-24
2024-08-22
Comment on STENOCARE’s Q2-report Report 2024
Video
2024-08-20
Interview with Pharma Equity Group’s CEO Thomas Kaas Selsø